322 related articles for article (PubMed ID: 21937435)
1. Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.
Ritchie TK; Kwon H; Atkins WM
J Biol Chem; 2011 Nov; 286(45):39489-96. PubMed ID: 21937435
[TBL] [Abstract][Full Text] [Related]
2. Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.
Li MJ; Nath A; Atkins WM
Biochemistry; 2017 May; 56(19):2506-2517. PubMed ID: 28441502
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
Shukla S; Robey RW; Bates SE; Ambudkar SV
Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
[TBL] [Abstract][Full Text] [Related]
4. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
Martin C; Higgins CF; Callaghan R
Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
[TBL] [Abstract][Full Text] [Related]
5.
Futamata R; Ogasawara F; Ichikawa T; Kodan A; Kimura Y; Kioka N; Ueda K
J Biol Chem; 2020 Apr; 295(15):5002-5011. PubMed ID: 32111736
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.
Ohnuma S; Chufan E; Nandigama K; Jenkins LM; Durell SR; Appella E; Sauna ZE; Ambudkar SV
Biochemistry; 2011 May; 50(18):3724-35. PubMed ID: 21452853
[TBL] [Abstract][Full Text] [Related]
7. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol Asymmetrically Modulates the Conformational Ensemble of the Nucleotide-Binding Domains of P-Glycoprotein in Lipid Nanodiscs.
Clouser AF; Alam YH; Atkins WM
Biochemistry; 2021 Jan; 60(1):85-94. PubMed ID: 33350827
[TBL] [Abstract][Full Text] [Related]
9. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.
Druley TE; Stein WD; Roninson IB
Biochemistry; 2001 Apr; 40(14):4312-22. PubMed ID: 11284687
[TBL] [Abstract][Full Text] [Related]
10. Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
Pitchakarn P; Ohnuma S; Pintha K; Pompimon W; Ambudkar SV; Limtrakul P
J Nutr Biochem; 2012 Jan; 23(1):76-84. PubMed ID: 21414769
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein.
Esser L; Shukla S; Zhou F; Ambudkar SV; Xia D
Acta Crystallogr F Struct Biol Commun; 2016 Aug; 72(Pt 8):636-41. PubMed ID: 27487928
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle.
Frank GA; Shukla S; Rao P; Borgnia MJ; Bartesaghi A; Merk A; Mobin A; Esser L; Earl LA; Gottesman MM; Xia D; Ambudkar SV; Subramaniam S
Mol Pharmacol; 2016 Jul; 90(1):35-41. PubMed ID: 27190212
[TBL] [Abstract][Full Text] [Related]
13. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle.
Rosenberg MF; Velarde G; Ford RC; Martin C; Berridge G; Kerr ID; Callaghan R; Schmidlin A; Wooding C; Linton KJ; Higgins CF
EMBO J; 2001 Oct; 20(20):5615-25. PubMed ID: 11598005
[TBL] [Abstract][Full Text] [Related]
14. P-Glycoprotein conformational changes detected by antibody competition.
Nagy H; Goda K; Arceci R; Cianfriglia M; Mechetner E; Szabó G
Eur J Biochem; 2001 Apr; 268(8):2416-20. PubMed ID: 11298761
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
Maki N; Moitra K; Ghosh P; Dey S
J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
[TBL] [Abstract][Full Text] [Related]
16. Computational Insights into Allosteric Conformational Modulation of P-Glycoprotein by Substrate and Inhibitor Binding.
Xing J; Huang S; Heng Y; Mei H; Pan X
Molecules; 2020 Dec; 25(24):. PubMed ID: 33353070
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.
Druley TE; Stein WD; Ruth A; Roninson IB
Biochemistry; 2001 Apr; 40(14):4323-31. PubMed ID: 11284688
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.
Jin MS; Oldham ML; Zhang Q; Chen J
Nature; 2012 Oct; 490(7421):566-9. PubMed ID: 23000902
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes.
Sauna ZE; Ambudkar SV
J Biol Chem; 2001 Apr; 276(15):11653-61. PubMed ID: 11154703
[TBL] [Abstract][Full Text] [Related]
20. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
Zhou Y; Gottesman MM; Pastan I
Arch Biochem Biophys; 1999 Jul; 367(1):74-80. PubMed ID: 10375401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
